ScholarLens Back to search
2002•Journal of Cystic FibrosisOpen access

Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis

John R. W. Govan

Open full text 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tobramycin, Colistin, Cystic fibrosis, Medicine, Pseudomonas aeruginosa, Antimicrobial, Antibiotics, Microbiology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis — Research Paper | ScholarLens